Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. - Wikidata - awgldk - TriplyDB

Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan.

Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan.

http://www.wikidata.org/entity/Q33893698

about

Pathogenesis and treatment of oral candidosis Candida albicans Biofilms and Human Disease Mechanisms of Candida biofilm drug resistance Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms Antifungal lock therapy Flo11p, drug efflux pumps, and the extracellular matrix cooperate to form biofilm yeast colonies.Post-transcriptional gene regulation in the biology and virulence of Candida albicans Hsp90 governs dispersion and drug resistance of fungal biofilms Development of a high-throughput Candida albicans biofilm chip A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance Transcriptional profiling of a yeast colony provides new insight into the heterogeneity of multicellular fungal communities An Optimized Lock Solution Containing Micafungin, Ethanol and Doxycycline Inhibits Candida albicans and Mixed C. albicans - Staphyloccoccus aureus Biofilms Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis Candida albicans Niche Specialization: Features That Distinguish Biofilm Cells from Commensal Cells.Novel carboline derivatives as potent antifungal lead compounds: design, synthesis, and biological evaluation.The Candida albicans Biofilm Matrix: Composition, Structure and Function A quantitative real-time RT-PCR assay for mature C. albicans biofilms.Novel entries in a fungal biofilm matrix encyclopedia Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene Nonsex genes in the mating type locus of Candida albicans play roles in a/α biofilm formation, including impermeability and fluconazole resistance.Fungal biofilms, drug resistance, and recurrent infection Elucidating drug resistance in human fungal pathogens.Exopolysaccharide matrix of developed Candida albicans biofilms after exposure to antifungal agents.Small-molecule suppressors of Candida albicans biofilm formation synergistically enhance the antifungal activity of amphotericin B against clinical Candida isolates.Rat indwelling urinary catheter model of Candida albicans biofilm infection.Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells.Pathogenic yeasts deploy cell surface receptors to acquire iron in vertebrate hosts.Optimizing a Candida biofilm microtiter plate model for measurement of antifungal susceptibility by tetrazolium salt assay Sustained release of a novel anti-quorum-sensing agent against oral fungal biofilms Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms Targeted disruption of nonribosomal peptide synthetase pes3 augments the virulence of Aspergillus fumigatus Community participation in biofilm matrix assembly and function Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation.Global transcriptome changes underlying colony growth in the opportunistic human pathogen Aspergillus fumigatus.An expanded regulatory network temporally controls Candida albicans biofilm formation.Identification of novel mechanisms involved in generating localized vulvodynia pain.Fungal biofilm resistance.Modeling of fungal biofilms using a rat central vein catheter.Yeast colonies: a model for studies of aging, environmental adaptation, and longevity.Candida albicans biofilms do not trigger reactive oxygen species and evade neutrophil killing.

P2860

Q24601191-C38B9F0C-AE18-40FB-AA96-8FDA35C1D3C7 Q26778729-053F16CB-8A65-4B86-82E9-E6D504A6333C Q26827521-05162532-6A24-4CF7-8222-9F40C41F9FB8 Q26861656-7C5BFB02-72C4-417E-9D74-116255C1F8D9 Q27025682-58C7D42A-7B09-41A1-8C2A-8CCEB2CAD6F9 Q27930431-697AEBB1-DC91-4E7D-A8BC-E12187F5A8AD Q28076944-2922A92B-CF4E-4D68-8646-B1C34F6AF4D0 Q28476836-57A9951A-B3FE-4763-9822-4AA726926AFB Q28477874-029857B1-A926-4246-AFD9-889924D2880F Q28481813-BA9661F3-B580-4954-91C1-32DF89D4847D Q28484115-22C92308-DF7B-47C0-AC6A-D51580257F20 Q28552679-E04723CA-47A7-4469-BD48-B5872F5F2DF2 Q28818603-607B734B-7558-4F10-A996-738376BEED9E Q33603993-4B1E6CFE-DED7-47E8-BF6F-76DF494CAC61 Q33636471-9EF1C917-0D6E-43F1-818F-06F3C6232AE1 Q33684840-50D58E42-D1BC-454C-AD44-5BC7C932F500 Q33891605-161FDC10-FDBB-459B-B195-18FB93068B5B Q34026267-F32E07D7-B223-4707-9F50-A7B0A1FB3480 Q34045325-2C94FC37-3487-4929-8B5D-4EB109D11BCA Q34130206-AA63822B-6C5C-40DB-A690-4751FD5D7942 Q34355341-EA292A86-1C35-41BA-B551-3207631E2DF9 Q34419351-0E34F697-F923-48B4-85CB-DF23EAB78FD5 Q34556646-48B0B4C1-99AF-422C-A0F6-3032A259204E Q34578357-395ED44B-57AA-45D8-AD73-F3556C7A8569 Q34595925-9534A332-6F3D-4C57-89C7-DC6BADE241E5 Q34932922-88DEA6DC-4FFF-4B90-9E15-F7E18F819FD1 Q34979350-306E65F9-F06A-41D9-BB04-ADE8BDC6AD93 Q35067093-91EBE1DF-5BDB-469C-B0BC-016CDE56E6B6 Q35168906-BDA8C4BA-2EEE-4693-B949-B615BDB0FAE1 Q35218859-8A1DC02F-BB03-4F21-BE8C-435A54FC6AD9 Q35272907-B306605B-97C5-4F07-8472-AB779CFFA2C1 Q35280502-FD8B6901-CF43-496D-B877-4D357EBEA414 Q35598281-0D22C07D-BFB8-4B47-AFE5-6DCBA5EC31A4 Q35666165-12C09373-A59C-41A2-B35D-E32811BA7250 Q35732526-250F7B69-AEE9-43FC-92DE-EE319CCC5757 Q35798360-E55750CD-27A5-4103-94C7-EC736C104973 Q35821475-B3D500FB-D038-4308-A6D8-A2102E363521 Q35926338-A3E102CE-9F5B-4D86-8F05-1B7BFA7A3279 Q36183974-4AF3DC00-4CFE-4703-B446-6FDD60B6507B Q36412239-71223C8B-65C3-417F-991B-ED652D0E7291

P2860

Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan.

http://www.wikidata.org/entity/Q33893698

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan.

@ast

Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan.

@en

type

label

Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan.

@ast

Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan.

@en

prefLabel

Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan.

@ast

Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan.

@en

P1433

Q33893698-05B3AEB3-D1E1-41C6-A4EF-E925FCD8C801

P1476

Q33893698-EFA2097D-3322-4C24-A78A-408EEB53117F

P2093

Q33893698-4ECF1B72-7C9C-4997-A863-D2B0484DC04B

Q33893698-5AF1CF1F-1090-46B9-AC0D-3B66B1BEFC7C

Q33893698-7E020C73-7719-42B5-A836-4987B4088A5E

P2860

Q33893698-0C8D47F6-D7EB-404C-B2D1-BEAE09FA6E24

Q33893698-17D940C5-FD8A-4263-AA98-610641E94B67

Q33893698-1BDE608D-30E0-41F4-BE98-BD722E29585A

Q33893698-25B285C0-874B-4096-9F89-1610BB1AC0EE

Q33893698-2C020737-63E9-4966-88A7-C5F8F27B108C

Q33893698-2C49641D-95EE-4D23-9841-8782BE24729E

Q33893698-3A853E2B-4359-4757-8170-7662B14C9EEA

Q33893698-5C5FCE0B-3645-4D49-A279-3FE9C8655E5D

Q33893698-6F3A076D-F0B7-41BA-A467-9EE5F9451D8F

Q33893698-77D924BB-98E8-46B5-A212-CD7BCE204C28

P304

Q33893698-F33EB88A-ECF9-4E6F-BFF3-4CECE639AA40

P31

Q33893698-8C9BE06A-FD30-45AF-B937-626D41CB3B41

P356

Q33893698-C45658A4-D03B-41B8-A22A-DAA95677418D

P407

Q33893698-914349F8-578D-4898-A521-95F4FC226501

P433

Q33893698-6A7F30EA-C8F6-499F-A133-8800E39A0F75

P478

Q33893698-1E30204E-BA53-4989-B9A0-B7444B6E8BF9

P50

Q33893698-91A6298F-0081-43E4-91F1-E3DA43ACC071

P577

Q33893698-B3541653-B1EF-4382-A920-395E3CF6FA8E

P5875

Q33893698-58EBC4E0-DF5F-4C5B-9741-F5543F1EEB29

P698

Q33893698-280D4C93-C2D8-43E5-8C9C-0013E0A916F0

P921

Q33893698-01E06969-625A-44C7-8C4C-346892C1BE89

P932

Q33893698-3D014F6A-2524-490F-972B-412D06FF7E5A

P356

P1433

The Journal of Infectious Diseases

P1476

Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan

@en

P2093

Hiram Sanchez

http://www.w3.org/2001/XMLSchema#string

Jeniel E Nett

http://www.w3.org/2001/XMLSchema#string

Michael T Cain

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of the Candida albicans homolog of Saccharomyces cerevisiae GSC1/FKS1 and its involvement in beta-1,3-glucan synthesis

RIM101-dependent and-independent pathways govern pH responses in Candida albicans.

Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery.

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.

Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols

Putative role of beta-1,3 glucans in Candida albicans biofilm resistance.

Development and characterization of an in vivo central venous catheter Candida albicans biofilm model.

New modules for PCR-based gene targeting in Candida albicans: rapid and efficient gene targeting using 100 bp of flanking homology region.

Complementary adhesin function in C. albicans biofilm formation.

P304

171-175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/651200

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

202

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44625129

http://www.w3.org/2001/XMLSchema#string

P698

20497051

http://www.w3.org/2001/XMLSchema#string

P921

P932

2880631

http://www.w3.org/2001/XMLSchema#string